Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho(Cornell University), James A. Fagin(Memorial Sloan Kettering Cancer Center), R. Michael Tuttle(Memorial Sloan Kettering Cancer Center), Ravinder K. Grewal, Somali Gavane, Steven M. Larson(Memorial Sloan Kettering Cancer Center), Julio C. Ricarte‐Filho, Rébecca Leboeuf(Memorial Sloan Kettering Cancer Center), Désirèe Deandreis, Pat Zanzonico, Eric J. Sherman, Sofia Haque, Ronald Ghossein, Ronglai Shen(Memorial Sloan Kettering Cancer Center), David G. Pfister(Memorial Sloan Kettering Cancer Center), Keith S. Pentlow, José Miguel Domínguez
Cited by 825
Related Papers
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
|Thyroid|2009|6.7k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k